COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (AMEX: CLN) today announced that, under an agreement reached on Friday, December 7, 2007, the Company has closed on the purchase of 659,738 shares of Celsion stock from Boston Scientific (NYSE:BSX) for $4.00 per share, for an aggregate price of $2,638,592. With the sale, Boston Scientific has informed the Company that it is no longer a holder of the Company’s common stock.
